➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: July 27, 2021

DrugPatentWatch Database Preview

Patent: 10,071,170

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 10,071,170
Title:Antibody-drug conjugate having improved stability and use thereof
Abstract: The present invention relates to an antibody-drug conjugate comprising a drug conjugated to an antibody, a preparation method thereof and the use thereof.
Inventor(s): Kim; Young Min (Gyeonggi-do, KR), Ko; Min Ji (Daejeon, KR), Kim; Jae Yong (Seoul, KR), Kim; Ju Hee (Daejeon, KR), Moon; Kyung Duk (Daejeon, KR), Song; Dae Hae (Daejeon, KR), Eom; Jae Hyun (Sejong, KR), Jung; Jin Won (Dajeon, KR)
Assignee: ABLBIO (Seoul, KR)
Application Number:14/898,126
Patent Claims:see list of patent claims

Details for Patent 10,071,170

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech Inc HERCEPTIN HYLECTA trastuzumab; hyaluronidase-oysk INJECTABLE;SUBCUTANEOUS 761106 001 2019-02-28 ⤷  Try it Free ABLBIO (Seoul, KR) 2033-06-24 RX search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ⤷  Try it Free ABLBIO (Seoul, KR) 2033-06-24 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 10,071,170

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 2014208987 ⤷  Try it Free
United States of America 2016136300 ⤷  Try it Free
United States of America 2018360986 ⤷  Try it Free
Russian Federation 2016102116 ⤷  Try it Free
Russian Federation 2670748 ⤷  Try it Free
South Korea 101641206 ⤷  Try it Free
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.